Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 1, 2001 - Issue 4
Submit an article Journal homepage
212
Views
36
CrossRef citations to date
0
Altmetric
Miscellaneous

VEGF antagonists

GC Jayson Cancer Research Campaign Dept. Medical Oncology, Christie Hospital, NHS Trust, Wilmslow Road, Withington, Manchester, , M20 4BX, UK, Tel.: +44 (0)161 446 3000 (extn 3606); , Fax: +44 (0)161 446 3299;, E-mail: [email protected]
&
J Hasan Cancer Research Campaign Dept. Medical Oncology, Christie Hospital, NHS Trust, Wilmslow Road, Withington, Manchester, , M20 4BX, UK, Tel.: +44 (0)161 446 3000 (extn 3606); , Fax: +44 (0)161 446 3299;, E-mail: [email protected]
Pages 703-718 | Published online: 23 Feb 2005

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Sameh R. Elgogary, Emad M. El‑Telbani & Rizk E. Khidre. (2023) Synthesis, Molecular Docking, and Antitumor Evaluation of Some New Pyrazole, Pyridine, and Thiazole Derivatives Incorporating Sulfonamide Residue. Polycyclic Aromatic Compounds 43:9, pages 7769-7782.
Read now
Ahmed M. Alafeefy, Saleh I. Alqasoumi, Abdelkader E. Ashour & Mashael M. Alshebly. (2013) Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing. Journal of Enzyme Inhibition and Medicinal Chemistry 28:2, pages 375-383.
Read now
AA Crawshaw, CEM Griffiths & HS Young. (2012) Investigational VEGF antagonists for psoriasis. Expert Opinion on Investigational Drugs 21:1, pages 33-43.
Read now
Fiona J Collinson, Geoff D Hall, Timothy J Perren & Gordon C Jayson. (2008) Development of antiangiogenic agents for ovarian cancer. Expert Review of Anticancer Therapy 8:1, pages 21-32.
Read now
Koji Morita, Koji Yamate, Shin-ichi Kurakata, Koji Abe, Kenji Watanabe, Makoto Koizumi & Takeshi Imanishi. (2006) Inhibition of VEGF mRNA by 2′-O,4′−C−Ethylene-Bridgednucleicacids (ENA®) Antisense Oligonucleotides and Their Influence on Off-Target Gene Expressions. Nucleosides, Nucleotides & Nucleic Acids 25:4-6, pages 503-521.
Read now
Martin J Calverley & Robert Gniadecki. (2002) Emerging drugs in psoriasis. Expert Opinion on Emerging Drugs 7:1, pages 69-90.
Read now

Articles from other publishers (30)

Geert Van Weelden, Marcin Bobiński, Karolina Okła, Willem Jan Van Weelden, Andrea Romano & Johanna M. A. Pijnenborg. (2019) Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms. Marine Drugs 17:1, pages 32.
Crossref
Trevor D. Crafts, Amanda R. Jensen, Ethan C. Blocher-Smith & Troy A. Markel. (2015) Vascular endothelial growth factor: Therapeutic possibilities and challenges for the treatment of ischemia. Cytokine 71:2, pages 385-393.
Crossref
Dhaval K. Shah & Joseph P. Balthasar. (2013) Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecan. Journal of Pharmacokinetics and Pharmacodynamics 41:1, pages 55-69.
Crossref
Robert Rees, Stephanie Laversin, Cliff Murray & Graham Ball. 2012. Vaccinology. Vaccinology 452 463 .
Julia Glade BenderDarrell J. YamashiroElizabeth Fox. (2011) Clinical Development of VEGF Signaling Pathway Inhibitors in Childhood Solid Tumors. The Oncologist 16:11, pages 1614-1625.
Crossref
Walter J. Lukiw & Frank Culicchia. 2011. Neurochemical Mechanisms in Disease. Neurochemical Mechanisms in Disease 799 821 .
Piotr Mysliwiec, Krystyna Pawlak, Roman Bandurski & Bogusław Kedra. (2009) Soluble angiogenesis markers in gastric tumor patients.. Folia Histochemica et Cytobiologica 47:1.
Crossref
Shereen El Tarhouny, Martin Seefeld, Alex Xiu-Cheng Fan, Sinuhe Hahn, Wolfgang Holzgreve & Xiao Yan Zhong. (2008) Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor. Cytokine 44:1, pages 65-69.
Crossref
Roberto Bianco, Roberta Rosa, Vincenzo Damiano, Gennaro Daniele, Teresa Gelardi, Sonia Garofalo, Valeria Tarallo, Sandro De Falco, Davide Melisi, Roberto Benelli, Adriana Albini, Anderson Ryan, Fortunato Ciardiello & Giampaolo Tortora. (2008) Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells. Clinical Cancer Research 14:16, pages 5069-5080.
Crossref
Liang Li, Christopher S. Gondi, Dzung H. Dinh, William C. Olivero, Meena Gujrati & Jasti S. Rao. (2007) Transfection with Anti-p65 Intrabody Suppresses Invasion and Angiogenesis in Glioma Cells by Blocking Nuclear Factor-κB Transcriptional Activity. Clinical Cancer Research 13:7, pages 2178-2190.
Crossref
Nirbhai Singh, Eric Higgins, Shivan Amin, Pooja Jani, Elizabeth Richter, Anup Patel, Rajwinder Kaur, Jin Wang, Jayakrishna Ambati, Zheng Dong & Balamurali K Ambati. (2007) Unique Homologous siRNA Blocks Hypoxia-Induced VEGF Upregulation in Human Corneal Cells and Inhibits and Regresses Murine Corneal Neovascularization. Cornea 26:1, pages 65-72.
Crossref
Charles J. Malemud. (2007) Growth hormone, VEGF and FGF: Involvement in rheumatoid arthritis. Clinica Chimica Acta 375:1-2, pages 10-19.
Crossref
C?leste Lebb?Delphine K?rob. (2006) Maladie de Kaposi. EMC - Dermatologie 1:1, pages 1-11.
Crossref
SVETOMIR N. MARKOVIC & ESTEBAN CELIS. 2006. Novel Anticancer Agents. Novel Anticancer Agents 207 221 .
Karsten Hemmrich, Klaus-D. Kröncke, Christoph V. Suschek & Victoria Kolb-Bachofen. (2005) What sense lies in antisense inhibition of inducible nitric oxide synthase expression?. Nitric Oxide 12:4, pages 183-199.
Crossref
Fan Fan, Jane S Wey, Marya F McCarty, Anna Belcheva, Wenbiao Liu, Todd W Bauer, Ray J Somcio, Yan Wu, Andrea Hooper, Daniel J Hicklin & Lee M Ellis. (2005) Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene 24:16, pages 2647-2653.
Crossref
Krishnamurthy P. Gudehithlu, Naila Ahmed, Henry Wu, Natalia O. Litbarg, Sandra L. Garber, Jose A.L. Arruda, George Dunea & Ashok K. Singh. (2005) Antagonism of vascular endothelial growth factor results in microvessel attrition and disorganization of wound tissue. Journal of Laboratory and Clinical Medicine 145:4, pages 194-203.
Crossref
Gordon C. Jayson, Clive Mulatero, Malcolm Ranson, Jamal Zweit, Alan Jackson, Lynn Broughton, John Wagstaff, Leif Hakansson, Gerard Groenewegen, Jeremy Lawrance, Meina Tang, Linda Wauk, Dan Levitt, Sandrine Marreaud, Frederic F. Lehmann, Manfred Herold & Heinz Zwierzina. (2005) Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer. European Journal of Cancer 41:4, pages 555-563.
Crossref
Gordon C. Jayson & John C. Waterton. 2005. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology 281 297 .
Bruno Vincenzi, Annalisa La Cesa, Daniele Santini, Gaia Schiavon, Claudia Grilli, Francesco Graziano & Giuseppe Tonini. (2004) Predictive factors for response to chemotherapy in colorectal cancer patients. Critical Reviews in Oncology/Hematology 52:1, pages 45-60.
Crossref
Srinivasan Madhusudan & Trivadi S. Ganesan. (2004) Tyrosine kinase inhibitors in cancer therapy. Clinical Biochemistry 37:7, pages 618-635.
Crossref
P. Rocha-Pereira, A. Santos-Silva, I. Rebelo, A. Figueiredo, A. Quintanilha & F. Teixeira. (2004) The inflammatory response in mild and in severe psoriasis. British Journal of Dermatology 150:5, pages 917-928.
Crossref
Jurjees Hasan & Gordon C Jayson. (2004) Vascular Endothelial Growth Factor Antagonists as Anticancer Agents. American Journal of Cancer 3:4, pages 229-245.
Crossref
T A Afanasieva, M Wittmer, A Vitaliti, M Ajmo, D Neri & R Klemenz. (2003) Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy. Gene Therapy 10:21, pages 1850-1859.
Crossref
Josef S. Smolen & Günter Steiner. (2003) Therapeutic strategies for rheumatoid arthritis. Nature Reviews Drug Discovery 2:6, pages 473-488.
Crossref
Kristin Ladell, Jochen Heinrich, Marc Schweneker & Karin Moelling. (2003) A combination of plasmid DNAs encoding murine fetal liver kinase 1 extracellular domain, murine interleukin-12, and murine interferon-γ inducible protein-10 leads to tumor regression and survival in melanoma-bearing mice. Journal of Molecular Medicine 81:4, pages 271-278.
Crossref
C. Lebbé & D. Kérob. (2003) Enfermedad de Kaposi. EMC - Dermatología 37:4, pages 1-12.
Crossref
Monica Gandhi & Ruth M Greenblatt. (2002) Human herpesvirus 8, Kaposi's sarcoma, and associated conditions. Clinics in Laboratory Medicine 22:4, pages 883-910.
Crossref
Jerry Adams, Pearl Huang & Denis Patrick. (2002) A strategy for the design of multiplex inhibitors for kinase-mediated signalling in angiogenesis. Current Opinion in Chemical Biology 6:4, pages 486-492.
Crossref
Jennifer F. Tseng & Richard C. Mulligan. (2002) Gene therapy for pancreatic cancer. Surgical Oncology Clinics of North America 11:3, pages 537-569.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.